CVS Group (LON:CVSG - Get Free Report) had its price objective raised by research analysts at Jefferies Financial Group from GBX 1,250 to GBX 1,420 in a research report issued to clients and investors on Wednesday,Digital Look reports. The brokerage currently has a "hold" rating on the stock. Jefferies Financial Group's price objective would indicate a potential upside of 0.57% from the company's previous close.
Several other equities analysts have also recently weighed in on CVSG. Peel Hunt reaffirmed a "buy" rating and issued a GBX 1,600 price target on shares of CVS Group in a research report on Tuesday, October 7th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the company a "buy" rating in a research report on Tuesday. Royal Bank Of Canada raised their price target on shares of CVS Group from GBX 1,500 to GBX 1,900 and gave the company an "outperform" rating in a research report on Tuesday. Finally, Berenberg Bank reissued a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a research report on Wednesday, October 15th. Four analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 1,724.
Check Out Our Latest Report on CVS Group
CVS Group Stock Down 0.6%
Shares of CVSG stock traded down GBX 8 on Wednesday, reaching GBX 1,412. 209,314 shares of the company were exchanged, compared to its average volume of 349,739. The company has a market cap of £1.01 billion, a price-to-earnings ratio of 371.58, a PEG ratio of 1.77 and a beta of 1.02. The company has a 50-day moving average of GBX 1,272.87 and a 200-day moving average of GBX 1,219.82. The company has a debt-to-equity ratio of 110.52, a current ratio of 1.09 and a quick ratio of 0.90. CVS Group has a one year low of GBX 791 and a one year high of GBX 1,648.
CVS Group (LON:CVSG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 earnings per share for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. Analysts anticipate that CVS Group will post 93.9393939 earnings per share for the current year.
CVS Group Company Profile
(
Get Free Report)
CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CVS Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Group wasn't on the list.
While CVS Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.